Verde Bio EBITDA margin
What is the EBITDA margin of Verde Bio?
The EBITDA margin of Verde Bio Holdings, Inc. is -342.66%
What is the definition of EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin of companies in the Finance sector on OTC compared to Verde Bio
What does Verde Bio do?
Verde Bio Holdings, Inc. engages in the oil and gas exploration and investment business. It has mineral and royalty interests in various properties. The company was formerly known as Appiphany Technologies Holdings Corp. and changed its name to Verde Bio Holdings, Inc. in May 2020. Verde Bio Holdings, Inc. was incorporated in 2010 and is based in Frisco, Texas.
Companies with ebitda margin similar to Verde Bio
- Exicure has EBITDA margin of -343.51%
- Exicure has EBITDA margin of -343.51%
- AdAlta has EBITDA margin of -343.26%
- Golden Valley Mines has EBITDA margin of -343.06%
- Golden Valley Mines has EBITDA margin of -343.06%
- Endexx has EBITDA margin of -342.80%
- Verde Bio has EBITDA margin of -342.66%
- Keyne Ltd has EBITDA margin of -342.52%
- Newfield Resources has EBITDA margin of -342.47%
- Genomic Vision Societe Anonyme has EBITDA margin of -342.13%
- Génomic Vision SA has EBITDA margin of -342.13%
- Remark Inc has EBITDA margin of -341.55%
- Versus Systems has EBITDA margin of -341.28%